NCT02046031View on ClinicalTrials.gov

Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.

PHASE4CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Ischemic Stroke
Interventions
DRUG

Ginkgolides Meglumine Injection

25 mg, ivdrip, once.

Trial Locations (1)

201129

The first affiliated hospital with Nanjing Medical University, Nanjing

Sponsors
All Listed Sponsors
collaborator

Beijing Bionovo Medicine Development Co., Ltd.

OTHER

lead

Jiangsu Kanion Pharmaceutical Co., Ltd

INDUSTRY

NCT02046031 - Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection. | Biotech Hunter | Biotech Hunter